Clinical trial
Prospective, Randomized, Double-Blind Trial of Abrupt and Tapered Interruption of Long-term Clopidogrel Therapy After Implantation of a Drug-Eluting Stent
NCT00640679 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Double-Blind Trial of Abrupt and Tapered Interruption of Long-term Clopidogrel Therapy After Implantation of a Drug-Eluting Stent
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2008
- Completion date
- August 31, 2012
- Enrollment
- 782 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.